Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-138013
Filing Date
2016-12-06
Accepted
2016-12-06 08:30:18
Documents
6
Period of Report
2016-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v454400_6k.htm 6-K 146189
2 GRAPHIC image_001.jpg GRAPHIC 4141
3 GRAPHIC image_002.jpg GRAPHIC 4141
4 GRAPHIC image_003.jpg GRAPHIC 4141
5 GRAPHIC image_005.jpg GRAPHIC 4141
6 GRAPHIC image_006.jpg GRAPHIC 4141
  Complete submission text file 0001144204-16-138013.txt   176395
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 162035237
SIC: 2834 Pharmaceutical Preparations